- Dihydroergocryptine in the Treatment of Parkinson's Disease
-
Sohn YH, Jeong Y, Seo SW, Kim SH, Kim JS
- KMID: 2286947
- Korean J Psychopharmacol.
- 2000 Jun;11(2):145-150.
OBJECTIVE: This study was performed to investigate the safety and clinical efficacy of Dihydroergocryptine (DHE) in Parkinson's disease. METHOD: Study subjects were 30 patients with idiopathic Parkinson's disease. DHE was administered orally... -
- CITED
-
- Close
- SHARE
-
- Close
